Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB
Defense World·2026-02-27 08:30
Aster Capital Management DIFC Ltd bought a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 13,210 shares of the financial services provider’s stock, valued at approximately $1,907,000. iShares Biotechnology ETF comprises about 1.0% of Aster Capital Management DIFC Ltd’s portfolio, making the stock its 14th largest position. Get iShares Biotechnology ETF alert ...